Perhaps future studies should implement serial analyses of neurofilament light and tau biomarkers in patients undergoing EVT under both GA and CS to further explore their relevance in relation to sedation modality and clinical stroke outcomes. This evidence concerns the gene MAPT and stroke disorder.